SPY772.04+0.09%QQQ745.40+0.12%BTC/USD83,277.00−1.38%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Vyome Holdings Inc (HIND) Stock Price, Quote, News & History

HINDNASDAQ
Trade with Public
Trade with Public
$2.04
-0.02-0.97%
At close: Sep 25, 5:00 PM EST
$1.95
-0.09-4.41%
After Hours: Sep 23, 8:28 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareStock Report

Vyome Holdings (HIND) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$2.07
Close
$2.04
Volume / Avg.
9.33K / 14.56K
Day Range
$2.01 - $2.08
52 Wk Range
1.75 - 6.56
Market Cap
$13.69M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
0.48%
Days to Cover
2.56

Recent Vyome Holdings Inc News

Deal Dispatch: Musk-Altman Drama, Ashton Kutcher SoHo House Play And We Pose Questions To Private Equity Pros

Elon's OpenAI bid flops, Vyome reviews Livechain, Peraso courts acquirers, GTCR faces antitrust and pizza chains go bankrupt.
Anthony Noto

Empery Digital, Riskified And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

PRO
Vyome Holdings' ReShape Lifesciences Has Received A Notice Of Allowance For A U.S. Patent Titled "VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATE".

https://patentcenter.uspto.gov/applications/18702356/ifw/docs
Benzinga Newsdesk

PRO
Vyome Holdings Appoints Jerry Leonard As CFO, Succeeding Robert Dickey IV, Who Served As Interim CFO Since August 2025

Finance executive with more than 25 years of experience brings extensive expertise in public company financial management, SEC reporting, financial operations, and governanceVyome Holdings, Inc. (NASDAQ:HIND)
Benzinga Newsdesk

PRO
Chardan Capital Initiates Coverage On Vyome Holdings with Buy Rating, Announces Price Target of $3.5

Chardan Capital analyst Keay Nakae initiates coverage on Vyome Holdings (NASDAQ:HIND) with a Buy rating and announces Price Target of $3.5.
Benzinga Newsdesk

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.58M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
13.15M
Free Cash Flow (TTM)
-5.58M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
7.57M

Analyst Trends and Forecast

1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$6.48M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
110.64
PB Ratio (TTM)
2.37
Earnings Yield % (TTM)
-78.98%
Earnings Yield % (FWD)
-37.75%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.86

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$7.89M
Debt to Equity
0.00
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.07
Close
$2.04
Volume / Avg.
9.33K / 14.56K
Day Range
$2.01 - $2.08
52 Wk Range
1.75 - 6.56
Market Cap
$13.69M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
0.48%
Days to Cover
2.56

About

Sector
Health Care
Industry
Pharmaceuticals
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Vyome Holdings (HIND) stock?

A

You can purchase shares of Vyome Holdings (NASDAQ:HIND) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vyome Holdings (HIND) competitors?

Q

What is the forecast, or price target, for Vyome Holdings (HIND) stock?

A

Vyome Holdings has a consensus price target of $9.25.

Q

What is the current price for Vyome Holdings (HIND)?

A

The stock price for Vyome Holdings (NASDAQ: HIND) is $1.95 last updated September 23, 2026 at 8:28 AM EDT.

Q

Does Vyome Holdings (HIND) pay a dividend?

A

There are no upcoming dividends for Vyome Holdings.

Q

When is Vyome Holdings (NASDAQ:HIND) reporting earnings?

A

Vyome Holdings does not have any upcoming earnings scheduled.

Q

Is Vyome Holdings (HIND) going to split?

A

There is no upcoming split for Vyome Holdings.

Q

What sector and industry does Vyome Holdings (HIND) operate in?

A

Vyome Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved